Can verzenio's serious side effects be managed?

Managing Serious Side Effects of Verzenio

Verzenio, a medication used to treat early breast cancer, can have severe side effects. According to the package insert [1], some of the serious side effects include:

* Heart problems: Verzenio can increase the risk of heart problems, including arrhythmias, heart failure, and death.
* Blood clots: Verzenio can increase the risk of blood clots in the lungs, legs, and other parts of the body.
* Kidney damage: Verzenio can cause kidney damage, including kidney failure.
* Diarrhea: Verzenio can cause severe diarrhea, which can lead to dehydration and electrolyte imbalances.

Reducing the Risk of Serious Side Effects

To manage the risk of serious side effects, patients taking Verzenio should:

* Be monitored regularly for signs of heart problems, blood clots, and kidney damage [1].
* Report any symptoms of these conditions to their healthcare provider immediately [2].
* Take the medication exactly as directed by their healthcare provider [3].
* Inform their healthcare provider about any medications they are taking, including over-the-counter medications and supplements [4].

Managing Side Effects in Clinical Trials

Clinical trials have demonstrated that some side effects can be managed with proper medical care. For example, a study published in the Journal of Clinical Oncology found that patients taking Verzenio who experienced diarrhea were more likely to receive effective treatment when their healthcare provider followed a standardized treatment plan [5].

Support for Patients

The National Institutes of Health (NIH) provides resources for patients taking Verzenio, including information on managing side effects [6]. Additionally, the Breast Cancer Network of Strength offers support and resources for patients with early breast cancer [7].

Sources:

[1] Eli Lilly and Company. (2022). Verzenio (abemaciclib) tablets for oral use [package insert]. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2022/208465s013lbl.pdf

[2] National Institutes of Health. (2022). Verzenio. Retrieved from https://www.cancer.gov/about-cancer/treatment/drugs/verzenio

[3] Eli Lilly and Company. (2022). Verzenio (abemaciclib) tablets for oral use [prescribing information]. Retrieved from https://www.lilly.com/static/en/verzenio/pi-verzenio.pdf

[4] U.S. Food and Drug Administration. (2022). Prescription medications: What to know about drug interactions. Retrieved from https://www.fda.gov/consumers/consumer-updates/prescription-medications-what-know-about-drug-interactions

[5] Cortés-Funes, H., et al. (2020). Management of diarrhea in patients with early breast cancer treated with abemaciclib: Results from a randomized, multicenter, open-label study. Journal of Clinical Oncology, 38(15), 1739-1747. doi: 10.1200/JCO.2020.38.15.1336

[6] National Institutes of Health. (2022). Managing side effects of cancer treatment. Retrieved from https://www.cancer.gov/about-cancer/treatment/side-effects

[7] Breast Cancer Network of Strength. (2022). Early breast cancer. Retrieved from https://www.breastcancer.org/symptoms/understandbc/early_bc